ANTIPYRINE

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
188.0 1.5 0 3 27.0 1 0.18
UNII
T3CHA1B51H
CAS
60-80-0
SYNONYMS
  • Antipyrine
  • Antipyrinum
  • Phenazone
  • Phenazone [inn]
  • Antipyrinum [hpus]
  • Antipyrine [usp]
  • Phenazone [ep]
  • Phenazone [mart.]
  • Antipyrine [mi]
  • Antipyrine [ii]
  • Antipyrine [usp-Rs]
  • Phenazone [who-Dd]
  • Antipyrine [vandf]
  • Nsc-7945
ZINC ID(s)
Availability
Present in 71 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT02153541 2014-07-01 Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults Phase 2 Not Yet Recruiting
NCT02037893 2013-11-01 Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media Phase 2 Completed

(Browse) Purchasable Analogs in ZINC

Dosages

Route Formulation Per Unit Dose
Ophthalmic Drops 0.1%
Ophthalmic Solution 0.1%

More Information

Usage Over Time

Comments